- Home
- AGNC vs LEGN Comparison
AGNC vs LEGN Comparison
Compare AGNC & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGNC
- LEGN
- Stock Information
- Founded
- AGNC 2008
- LEGN 2014
- Country
- AGNC United States
- LEGN United States
- Employees
- AGNC N/A
- LEGN N/A
- Industry
- AGNC Real Estate Investment Trusts
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- AGNC Real Estate
- LEGN Health Care
- Exchange
- AGNC Nasdaq
- LEGN Nasdaq
- Market Cap
- AGNC 10.7B
- LEGN 6.7B
- IPO Year
- AGNC 2008
- LEGN 2020
- Fundamental
- Price
- AGNC $10.19
- LEGN $33.88
- Analyst Decision
- AGNC Buy
- LEGN Strong Buy
- Analyst Count
- AGNC 8
- LEGN 12
- Target Price
- AGNC $9.63
- LEGN $73.36
- AVG Volume (30 Days)
- AGNC 19.3M
- LEGN 1.1M
- Earning Date
- AGNC 10-20-2025
- LEGN 11-11-2025
- Dividend Yield
- AGNC 14.14%
- LEGN N/A
- EPS Growth
- AGNC N/A
- LEGN N/A
- EPS
- AGNC 0.26
- LEGN N/A
- Revenue
- AGNC $496,000,000.00
- LEGN $796,838,000.00
- Revenue This Year
- AGNC $9.87
- LEGN $70.75
- Revenue Next Year
- AGNC $58.56
- LEGN $52.47
- P/E Ratio
- AGNC $39.55
- LEGN N/A
- Revenue Growth
- AGNC N/A
- LEGN 74.75
- 52 Week Low
- AGNC $7.85
- LEGN $27.34
- 52 Week High
- AGNC $10.85
- LEGN $52.31
- Technical
- Relative Strength Index (RSI)
- AGNC 64.11
- LEGN 41.24
- Support Level
- AGNC $10.14
- LEGN $32.70
- Resistance Level
- AGNC $9.86
- LEGN $34.71
- Average True Range (ATR)
- AGNC 0.13
- LEGN 1.18
- MACD
- AGNC 0.01
- LEGN -0.06
- Stochastic Oscillator
- AGNC 69.51
- LEGN 31.31
About AGNC AGNC Investment Corp.
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.